Clinical trials
Dystocia trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2022 | 4 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 5 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 3 |
| Karolinska Institutet | 3 |
| Christiana Care Health Services | 2 |
| Wake Forest University Health Sciences | 2 |
| Assuta Ashdod Hospital | 1 |
| Baylor Research Institute | 1 |
| Biruni University | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Copenhagen University Hospital, Hvidovre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dystocia | 29 |
| Labor Pain | 2 |
| Obstetric Labor Complications | 2 |
| Wounds and Injuries | 2 |
| Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 1 |
| Disease Progression | 1 |
| Encopresis | 1 |
| Fecal Incontinence | 1 |
| Fetal Hypoxia | 1 |
| Hemorrhage | 1 |
Trials
Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.